参考文献/References:
[1]王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志,2016,44(5):14-16.[2]林青,王佳佳,孙明华,等.心脏磁共振压缩感知电影序列的临床应用[J].中国医学影像技术,2020,36(2):281-286.[3]齐迪雅,陆远,王志荣.心脏磁共振评估急诊PCI后STEMI患者预后的应用分析[J].中国循证心血管医学杂志,2020,12(1):95-99.[4]Arnold JR,McCann GP.Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist[J].Heart,2020,106(3):174-181.[5]Piechnik SK,Ferreira VM,Dall’Armellina E,et al.Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinicalmyocardial T1-mapping at 1.5 and 3 T within a 9heartbeat breathhold[J].J Cardiovasc Magn Reson,2010,12(1):69. [6]Jan MF,Tajik AJ.Modern imaging techniques in car-diomyopathies[J].Circ Res,2017,121(7):874-891. [7]Liu Y,Hamilton J,Rajagopalan S,et al.Cardiacmagnetic resonance fingerprinting: technical overviewand initial results[J].JACC:Cardiovascular Imaging,2018,11(12):1837-1853. [8]Luetkens JA,Schlesinger-Irsch U,Kuetting DL,et al.Feature-tracking myocardial strain analysis in acute myocarditis: diagnostic value and association with myocardial oedema[J].Eur Radiol,2017,27(11):4661-4671.[9]Engblom H,Xue H,Akil S,et al.Fully quantitative cardiovascular mag-netic resonance myocardial perfusion ready for clinicaluse:a comparison between cardiovascular magneticresonance imaging and positron emission tomography[J].J Cardiovasc Magn Reson,2017,19(1):78. [10]Valkovic L,Clarke WT,Schmid AI,et al.Measuring inorganic phosphate andintracellular pH in the healthy and hypertrophic car-diomyopathy hearts by in vivo 7T 31P-cardiovascularmagnetic resonance spectroscopy[J].J Cardiovasc Magn Reson,2019,21(1):19. [11]Tran N,Giannakidis A,Gullberg GT,et al.Quantita-tive analysis of hypertrophic myocardium using diffu-sion tensor magnetic resonance imaging[J].J Med Imaging (Bellingham, Wash),2016,3(4):046001. [12]Lakdawala NK,Winterfield JR,Funke BH.Dilated car-diomyopathy[J].Circ Arrhythm Electrophysiol,2013,6(1):228-237. [13]洪雪冬,郑穗生,许玲,等.心脏磁共振对原发扩张性心肌病左心整体功能和心肌纤维化的应用研究[J].中华全科医学,2019,17(4):633-636,665.[14]Di Marco A,Anguera I,Schmitt M,et al.Late gadolinium enhancement and therisk for ventricular arrhythmias or sudden death indilated cardiomyopathy:systematic review and meta-analysis[J].JACC Heart Fail,2017,5(1):28-38. [15]Puntmann VO,Carr-White G,Jabbour A,et al.T1-mapping and outcome innonischemic cardiomyopathy:all-cause mortality andheart failure[J].JACC Cardiovasc Imaging,2016,9(1):40-50. [16]Holloway CJ,Suttie J,Dass S,et al.Clinical Cardiac Magnetic Resonance Spectroscopy[J]. Progress in Cardiovascular Diseases,2011,54(3):320-327.[17]Friedrich MG,Sechtem U,Schulz-Menger J,et al.Cardiovascular magneticresonance in myocarditis:A JACC White Paper[J].J AmColl Cardiol,2009(53):1475-1487. [18]Ferreira VM,Schulz-Menger J,Holmvang G,et al.Cardiovascular magnetic resonance in nonischemic myocardial inflammation[J].Expert Recommendations,2018(72):3158-3176. [19]Grani C,Eichhorn C Bière L,et al.Prognostic value of cardiac magneticresonance tissue characterization in risk stratifying patients with suspected myocarditis[J].J Am Coll Cardiol,2017,70(16):1964-1976. [20]Cao Y,Zhang PY.Review of recent advances in themanagement of hypertrophic cardiomyopathy[J].EurRev Med Pharmacol Sci,2017,21(22):5207-5210. [21]Weng Z,Yao J,Chan RH,et al.Prognostic value of LGE-CMR in HCM:a meta-analysis[J].JACC Cardiovasc Imaging,2016,9(12):1392-1402. [22]Todiere G,Pisciella L,Barison A,et al.Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability[J].PLoS One,2014,9(10):e111366. [23]Muchtar E,Blauwet LA,Gertz MA.Restrictive cardio-myopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy[J].Circ Res,2017,121(1):819-837. [24]Fontana M,Pica S,Reant P,et al.Prognostic value of late gadolin-ium enhancement cardiovascular magnetic resonancein cardiac amyloidosis[J].Circulation,2015,132(16):1570-1579. [25]Arani A,Arunachalam SP,Chang ICY,et al.Cardiac MR elastographyfor quantitative assessment of elevated myocardialstiffness in cardiac amyloidosis[J].J Magn Reson Imaging,2017,46 (5):1361-1367. [26]Kwon DH,Asamoto L,Popovic ZB,et al.Infarct characterization andquantification by delayed Enhancement cardiac mag-netic resonance imaging is a powerful independentand incremental predictor of mortality in patients withadvanced ischemic cardiomyopathy[J].Circ CardiovascImaging,2014,7(5):796-804. [27]Aquaro GD,Pingitore A,Di Bella G,et al.Prognostic role of cardiac magneticresonance in Arrhythmogenic right ventricular cardio-myopathy[J].Am J Cardiol,2018,122(10):1745-1753.
相似文献/References:
[1]陈智红,成官迅.心脏磁共振定量成像评价心肌疾病的应用[J].医学信息,2019,32(08):8.[doi:10.3969/j.issn.1006-1959.2019.08.003]
CHEN Zhi-hong,CHENG Guan-xun.Application of Cardiac Magnetic Resonance Quantitative Imaging in the Evaluation of Myocardial Diseases[J].Medical Information,2019,32(07):8.[doi:10.3969/j.issn.1006-1959.2019.08.003]
[2]张雪杰.多元化健康教育对学龄期心肌病患儿遵医行为及护理满意度的影响[J].医学信息,2020,33(22):186.[doi:10.3969/j.issn.1006-1959.2020.22.055]
ZHANG Xue-jie.Effect of Diversified Health Education on Compliance Behavior and Nursing Satisfaction of School-age Children with Cardiomyopathy[J].Medical Information,2020,33(07):186.[doi:10.3969/j.issn.1006-1959.2020.22.055]
[3]郭 夏,郑 辉,李雪粉,等.糖尿病大鼠心肌损伤模型的诱导及对血清瘦素水平的影响[J].医学信息,2021,34(19):81.[doi:10.3969/j.issn.1006-1959.2021.19.020]
GUO Xia,ZHENG Hui,LI Xue-fen,et al.Induction of Myocardial Injury in Diabetic Rats and its Effect on Serum Leptin Level[J].Medical Information,2021,34(07):81.[doi:10.3969/j.issn.1006-1959.2021.19.020]
[4]狄多多,朱 熠,李博伟,等.心脏磁共振特征追踪技术在肥厚型心肌病左室心肌应变中的应用研究[J].医学信息,2023,36(12):107.[doi:10.3969/j.issn.1006-1959.2023.12.020]
DI Duo-duo,ZHU Yi,LI Bo-wei,et al.Quantitative Evaluation of Left Ventricular Myocardial Strain in Hypertrophic Cardiomyopathy by Cardiac Magnetic Resonance Feature Tracking Technique[J].Medical Information,2023,36(07):107.[doi:10.3969/j.issn.1006-1959.2023.12.020]